Skip to main content

Table 1 Baseline Characteristics (n = 91)

From: A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis

Variables

N (%)

Age

Median 59 (range 33–75)

Sex

 Male

68 (74.33)

 Female

23 (25.27)

ECOG PS

 0

83 (91.21)

 1

8 (8.79)

Histologic differentiation

 Well differentiated

30 (32.97)

 Moderately differentiated

60 (65.93)

 Poorly differentiated

1 (1.10)

Clinical T stage

 cT3

88 (96.70)

 cT4

3 (3.30)

Clinical N stage

 

 Negative

12 (13.19)

 Positive

79 (86.81)

CEA

  < 5 ng/ml

58 (65.91)

  ≥ 5 ng/ml

30 (34.09)

Distance from anal verge

Median 6cm, range 1–8cm

  1. Abbreviation: ECOG PS Eastern Cooperative Oncology Group performance status, CEA carcinoembryonic antigen